Anika Appoints Sheryl Conley to Board of Directors

Rhea-AI Summary

Anika Therapeutics has appointed Sheryl Conley as an independent director to its Board, effective October 28, 2021. With over 35 years in the orthopedic field, including roles at OrthoWorx and Zimmer, Conley's expertise in marketing, sales, and product development is expected to enhance Anika's strategic objectives. This appointment increases the number of independent directors to seven, supporting Anika's goal to become a leading joint preservation company. Conley also holds positions on the boards of other healthcare companies, further showcasing her industry influence.

Positive

• Sheryl Conley's extensive experience in orthopedic and healthcare industries.
• Her prior leadership roles at Zimmer, where she contributed to the commercialization of over 50 brands.
• Conley's appointment strengthens Anika's Board with significant industry knowledge.

Negative

• None.

Appointment brings experienced orthopedic industry commercial leader to Anika’s Board

BEDFORD, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that its Board of Directors has appointed Sheryl Conley as independent director, effective October 28, 2021.

Sheryl Conley joins the Anika Board of Directors with over 35 years of orthopedic and healthcare industry experience, most recently as President and CEO of OrthoWorx, Inc., and previously as Group President, Americas and Global Brand Management, and Chief Marketing Officer for Zimmer, Inc. Ms. Conley brings extensive orthopedic medical device industry knowledge with a focus on global brand management, marketing, sales, product development and operations. Ms. Conley will serve on the Audit Committee. This appointment brings the total number of independent directors to seven.

“We are pleased to have Sheryl join our Board of Directors as Anika executes on its strategy to transform into a leading joint preservation company,” commented Cheryl R. Blanchard, Ph.D., President and Chief Executive Officer of Anika. “I have known Sheryl for many years as an innovator and leader in the orthopedic industry and her commercial experience in orthopedics is second to none. She spent more than 25 years at Zimmer in escalating management roles, including as Group President across a variety of product segments and geographies, during which she provided key leadership in the development and commercialization of over 50 industry leading brands. We are very excited for her to bring those experiences to the Anika Board.”

Jeff Thompson, Anika’s Chair of the Board, commented, “Adding Sheryl brings a high degree of industry knowledge, including significant experience in operating fully integrated orthopedic businesses, which will help guide Anika through its transformational journey as it becomes a leading joint preservation company. I look forward to working with Sheryl in her new role.”

Sheryl Conley is currently President and Board Member of AcceLINX, Inc., a musculoskeletal health business accelerator. She also serves on the Board of Directors for Neuronetics, Inc. (NASDAQ: STIM), since October 2019, where she is a member of the Audit and Nominating and Governance Committees. She also serves on the Board for Surgalign, Inc. (NASDAQ: SRGA), since May 2021, where in addition to her role as Chair, she is a member of the Audit Committee. She holds a Bachelor of Science (Biology and Chemistry) and an MBA from Ball State University (IN).

About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with physicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world. We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies. For more information, please visit www.anika.com.

For Investor Inquiries:
Anika Therapeutics, Inc.
Mark Namaroff, 781-457-9287
Executive Director, Investor Relations and Corporate Communications
investorrelations@anika.com

FAQ

Who has been appointed to the Board of Anika Therapeutics?

Sheryl Conley has been appointed as an independent director of Anika Therapeutics.

What is Sheryl Conley's previous experience?

Sheryl Conley has over 35 years of experience in the orthopedic industry, including roles as President and CEO of OrthoWorx and Group President at Zimmer.

When did Sheryl Conley join Anika's Board?

Sheryl Conley joined Anika Therapeutics' Board of Directors on October 28, 2021.

How does Sheryl Conley's appointment impact Anika?

Her appointment is expected to guide Anika through its transformation into a leading joint preservation company.